You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KNSA Exercise Disclosure
Patel Sanj K · SEC Form 4 · Filed Nov 6, 2026
Exercise
Calculated transaction value
$2.61M
Patel Sanj K Chairman & CEO
KNSA
Transaction date
Nov 4, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 2 days later
KNSA daily price context
Close on/before transaction
$96.12
Nov 4, 2026
First close after public filing
$98.76
Nov 9, 2026
Return after filing · so far
-3.03%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Share
- Quantity / price
- 145,763 shares @ $17.92
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001532218-26-000020
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$16.94M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc KNSA | Sale | Nov 4, 2026 | $1.06M |
| Kiniksa Pharmaceuticals International, Plc KNSA | Sale | Nov 4, 2026 | $2.85M |
| Kiniksa Pharmaceuticals International, Plc KNSA | Sale | Nov 4, 2026 | $2.59M |
| Kiniksa Pharmaceuticals International, Plc KNSA | Sale | Nov 4, 2026 | $7.7M |
| Kiniksa Pharmaceuticals International, Plc KNSA Current | Exercise | Nov 4, 2026 | $2.61M |
| Kiniksa Pharmaceuticals International, Plc KNSA | Sale | Nov 4, 2026 | $134.83K |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Nov 4, 2026 | $0 |